AimVion is preparing for its series A investment round and is actively looking for investors.

We are also looking for collaboration with partners, both academic and industrial, who can use our anti-inflammatory peptides in their areas of interest or are interested in clinical co-development of our lead compound.

If you see any opportunity for collaboration or are interested in hearing more about an investment opportunity please do not hesitate to contact us.